Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates
- María Del Mar Tavío(corresponding author),
- Jordi Vila,
- ,
- José Ruiz,
- Antonio Manuel Martín-Sánchez,
- María Teresa Jiménez De Anta
- University of Las Palmas de G.C.,
- Hospital Clínic – Universitat de Barcelona,
Open access
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 735-742 (8 pages)Journal (Volume, Issue Number)
Journal of Antimicrobial Chemotherapy (Volume 44, Issue 6)Publication milestones
- Published - 1999
Publication status
ISSN
0305-7453Publication IDs
- Scopus: 0032805684
- PubMed: 10590273
Abstract
Eighteen quinolone-resistant isolates of Escherichia coli were selected by exposing ten clinical isolates to increasing concentrations of norfloxacin and lomefloxacin. The mutant isolates showed a multiple-antibiotic-resistance phenotype. All of them contained single mutations in gyrA consisting of the substitution of Ser-83→Leu (n = 14), Val (n = 1) or Ala (n = 1) and the substitution of Asp-87→Asn (n = 2). Only one concomitant mutation in parC (Ser-80→Arg) was detected. Four parent isolates exhibited a single mutation in gyrA which required ≤ 1 mg/L of norfloxacin to be inhibited. Fluoroquinolone resistance, in the 18 quinolone-resistant mutants, was a result of mutations affecting DNA gyrase plus decreased fluoroquinolone uptake. This latter mechanism of resistance was a combined effect of an absence of OmpF and an increase in active efflux in eight isolates, or an increased active efflux alone in the remaining ten selected mutants.
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
